98 related articles for article (PubMed ID: 19028098)
1. Tumour location is not an independent prognostic factor for survival following a diagnosis of breast cancer.
Jayasinghe UW; Boyages J
Breast; 2009 Feb; 18(1):41-6. PubMed ID: 19028098
[TBL] [Abstract][Full Text] [Related]
2. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
Jayasinghe UW; Bilous AM; Boyages J
Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
[TBL] [Abstract][Full Text] [Related]
3. Elevated preoperative serum ICTP is a prognostic factor for overall and disease-free survival in breast cancer.
Keskikuru R; Bloigu R; Risteli J; Kataja V; Jukkola A
Oncol Rep; 2002; 9(6):1323-7. PubMed ID: 12375042
[TBL] [Abstract][Full Text] [Related]
4. Tumor location of the lower-inner quadrant is associated with an impaired survival for women with early-stage breast cancer.
Sarp S; Fioretta G; Verkooijen HM; Vlastos G; Rapiti E; Schubert H; Sappino AP; Bouchardy C
Ann Surg Oncol; 2007 Mar; 14(3):1031-9. PubMed ID: 17176985
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival.
Tommiska J; Eerola H; Heinonen M; Salonen L; Kaare M; Tallila J; Ristimäki A; von Smitten K; Aittomäki K; Heikkilä P; Blomqvist C; Nevanlinna H
Clin Cancer Res; 2005 Jul; 11(14):5098-103. PubMed ID: 16033823
[TBL] [Abstract][Full Text] [Related]
6. Primary tumor location impacts breast cancer survival.
Sohn VY; Arthurs ZM; Sebesta JA; Brown TA
Am J Surg; 2008 May; 195(5):641-4. PubMed ID: 18424280
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis between patients with invasive ductal and invasive lobular breast cancer.
Dian D; Herold H; Mylonas I; Scholz C; Janni W; Sommer H; Friese K
Arch Gynecol Obstet; 2009 Jan; 279(1):23-8. PubMed ID: 18449551
[TBL] [Abstract][Full Text] [Related]
8. Tumour location and prognostic characteristics as determinants of survival of women with invasive breast cancer: South Australian hospital-based cancer registries, 1987-1998.
Gill PG; Birrell SN; Luke CG; Roder DM
Breast; 2002 Jun; 11(3):221-7. PubMed ID: 14965671
[TBL] [Abstract][Full Text] [Related]
9. Differences between male and female breast cancer. III. Prognostic features.
Rudan I; Rudan N; Basić N; Basić V; Rudan D; Jambrisak Z
Acta Med Croatica; 1997; 51(3):135-41. PubMed ID: 9248110
[TBL] [Abstract][Full Text] [Related]
10. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
[TBL] [Abstract][Full Text] [Related]
11. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer.
Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G
Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389
[TBL] [Abstract][Full Text] [Related]
12. Interval breast cancers: prognostic features and survival by subtype and time since screening.
Porter GJ; Evans AJ; Burrell HC; Lee AH; Ellis IO; Chakrabarti J
J Med Screen; 2006; 13(3):115-22. PubMed ID: 17007651
[TBL] [Abstract][Full Text] [Related]
13. Age and ethnicity as prognostic factors influencing overall survival in breast cancer patients in the Auckland region. Auckland Breast Cancer Study Group.
Lethaby AE; Mason BH; Holdaway IM; Kay RG
N Z Med J; 1992 Dec; 105(947):485-8. PubMed ID: 1461604
[TBL] [Abstract][Full Text] [Related]
14. Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series.
Viale G; Rotmensz N; Maisonneuve P; Orvieto E; Maiorano E; Galimberti V; Luini A; Colleoni M; Goldhirsch A; Coates AS
Breast Cancer Res Treat; 2009 Sep; 117(1):211-4. PubMed ID: 18629634
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution.
Orvieto E; Maiorano E; Bottiglieri L; Maisonneuve P; Rotmensz N; Galimberti V; Luini A; Brenelli F; Gatti G; Viale G
Cancer; 2008 Oct; 113(7):1511-20. PubMed ID: 18704988
[TBL] [Abstract][Full Text] [Related]
16. The prognostic influence of multifocality in breast cancer patients.
Pedersen L; Gunnarsdottir KA; Rasmussen BB; Moeller S; Lanng C
Breast; 2004 Jun; 13(3):188-93. PubMed ID: 15177420
[TBL] [Abstract][Full Text] [Related]
17. Bilateral breast cancer.
Pomerantz RA; Murad T; Hines JR
Am Surg; 1989 Jul; 55(7):441-4. PubMed ID: 2545121
[TBL] [Abstract][Full Text] [Related]
18. Early-stage breast cancer rates rise sharply as invasive breast cancer levels off.
Oncology (Williston Park); 2005 Aug; 19(9):1176. PubMed ID: 16404785
[No Abstract] [Full Text] [Related]
19. CD24 expression has a prognostic impact in breast carcinoma.
Athanassiadou P; Grapsa D; Gonidi M; Athanassiadou AM; Tsipis A; Patsouris E
Pathol Res Pract; 2009; 205(8):524-33. PubMed ID: 19243896
[TBL] [Abstract][Full Text] [Related]
20. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
Bharat A; Gao F; Margenthaler JA
Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
